It has been more than 5 years since New York State mandated that HIV tests be offered to patients between the ages of 13 and 64 be offered HIV tests in hospital emergency settings. Despite this offer many are refusing to be tested for a variety of reasons.
If research continues focusing on macrophages and their role in the human immunodeficiency virus (HIV), it could mean new opportunities to treat patients and eventually help find a cure.
Former Two and a Half Men star Charlie Sheen divulged on the TODAY show Tuesday morning that he is infected with HIV (human immunodeficiency virus). And while it can impact everyday life, it is not the be-all and end-all disease that it once was in the 80's.
Although there are now effective treatments for several genotypes of hepatitis C, certain patient groups continue to present challenges for the pharmaceutical and medical communities. Work is being done to overcome those challenges around the world.
A herpes medication can reduce HIV activity, according to researchers from Case Western Reserve.
Researchers at Rockefeller University in New York City suggest that a member of a new generation of broadly neutralizing antibodies to HIV appears to reduce the viral load of patients with the infection and significantly reduce viremia through 28 days.
Sitagliptin appears to have beneficial systemic and adipose anti-inflammatory effects in combination antiretroviral therapy-treated HIV-positive adults with impaired glucose tolerance. The drug may prevent cardiovascular problems by reducing inflammation linked to heart disease and stroke in this patient population.
An estimated 3.3% of people in the United States born between 1945 and 1965 have chronic hepatitis C infection. The increased risk of infection in this population has recently led the Centers for Disease Control and Prevention (CDC) to recommend one-time hepatitis C virus (HCV) testing for all persons in this age cohort.
The International Antiviral Society–USA Panel has released its 2014 report, which provided clinical recommendations to stop HIV transmission.
Men who have sex with men and women (MSMW) have unique vulnerability to HIV and sexually transmitted infections (STIs) and other sexual health problems, according to a review published online June 22 in American Journal of Preventive Medicine.
By growing vaginal skin cells outside of the human body, a team of researchers has pinpointed which bacteria fight against HIV.
Implementation of computerized customized order entry sets in a large urban hospital reduced HIV medication error rates by more than 35%.
Study results presented at the 2013 United States Conference on AIDS show that both combo drugs have a similar efficacy profile in ART-naïve patients, but patients treated with Complera reported fewer and less severe side effects.
Increased spending for treatment of HIV patients does not necessarily lead to a more positive clinical outcome, according to a new study presented at the 2013 United States Conference on AIDS.
When alcohol consumption is a concern, it's better to prescribe antiretroviral therapy in HIV patients than to withhold it, according to a group of researchers at University Hospital of Berne in Switzerland.
Researchers report that efavirenz may produce a potent neurotoxic effect that may contribute to neurocognitive decline in HIV-infected patients who take the drug long-term.
Speaking multiple languages may help protect cognitive health over the long term.
